Research addressing
the biggest challenges
in neural science today

Approach
Revolutionizing patient centric rapid response variant specific Post RNA Virus nervous system disorders research.

We are a research center accelerating Long COVID neurological research.

We work to understand the biomechanics of how emerging SARS-CoV-2 variants of concern attack the Central and Peripheral Nervous System resulting in neurological disorders.

Bold Rigorous Research

Seeking early detection, injury intervention and damage prevention of Long COVID.

Next-Gen Technology

Advancing diagnosis, monitoring, and treatment protocols via computational nuerosimulation.

Rapidly transforming research into actions by focusing on projects with the highest likelihood of leading to clinical trials and approved treatments in the near term.

Research

Neurological research that positively impacts the lives of 42 million North American Long COVID sufferers.

Proactive, responsive and agile, we are unafraid to refocus neurological research priorities and resources to face emerging RNA variant challenges.

Our core research centers on three primary neurological impact concerns – direct infection, neuro autoimmunity, and distal inflammation.

Direct Infection
Direct Infection

Researching genetic
material in nervous system tissue including spiked protein evidencing SARS-CoV-2 capability of infecting and replicating directly within the human brain.

Neuro Autoimmunity
Neuro Autoimmunity

Researching evidence of antibody coated brain blood vessels resulting in significant structural damage and brain tissue inflammation.

Distal Inflammation
Distal Inflammation

Researching SARS-CoV-2 attack on the “support cells” of the brain in the reticular formation – those that ensure neurons are able to keep the brain and body functioning.

Team

SYMLOGX comprises a deeply experienced dedicated and persevering research, advisory, academic, and technology collaboration team steadfastly devoted to improving the lives of the people we serve.

Leadership
team
Advisor
team
Alliance
team
Technology
team
Methods

At the intersection of exceptional medical talent and computational AI excellence we emerge as leaders in post COVID neural science research. Our diverse methods include human cell cultures, pre-clinic product studies, meta-analysis and biomedical research.

  • RNA Virus SARS-CoV-2 Brain Infection

    This branch of our research into post-acute sequelae of Post RNA Virus examines direct brain infection. Via a longitudinal cohort study, we leverage biological systems, neurological function measures, physical neurocognitive performance, and patient-reported outcome methodologies, hierarchical logistic regression modelling and cluster analysis using the K-medoids clustering approach with a focus on pre-clinical outcomes.

  • RNA Virus SARS-CoV-2 Neuro Autoimmunity

    Inspecting the mechanisms of the RNA virus intrinsic immune recognition and its initiation of adaptive antiviral immunity. This involves a particular focus on the natural site of the virus’s encounter within the brain’s vascular system, resulting in antibody-coated blood vessels and structural damage. Research mothodolgy includes leveraging blood tests, blood vessel scans, bioinformatics, MRI/MRA imaging, genetic studies, and primary computational simulation as data sources for further analysis.

  • RNA Virus SARS-CoV-2 Distal Inflammation

    Here, we conduct cross-sectional research into the neurological manifestations of post-RNA virus infection. We focus on microvascular damage pathology and brain stem immune profiling, as evidenced by bilateral Reticular hyperintensities in MRI/MRA imaging. Research methods include biopsy sampling, 165 ribosomal RNA gene survey, cluster analysis and phenotype-guided analysis.

News

Monthly articles, features, publishings and global insights into Long COVID research.

04 February 2024 - Feature

3D-Printed Brain Tissue

Printed tissue cells developed into functional neurons in a matter of weeks. The approach could be used to repair RNA Virus damage in the brain.

Keep reading
17 January 2024 - Research

CNS and Mitochondria

Patients suffering from Long COVID exhibit a reduced neurological performance and impaired mitochondrial repair functioning.

Keep reading
14 December 2023 - Article

COVID Brain Damage

RNA viral associated systemic and CNS inflammation are resulting in brain nerve damage.

Keep reading
17 November 2023 - Article

Significant JN.1 Variant

As a pathogen JN.1 represents a surprisingly new-look version of SARS-CoV-2 and is rapidly displacing other circulating strains (omicron XBB).

Keep reading
18 September 2023 - Research

VIRLOGX Chronic Covid Care

Advanced AI-based models applied in Long COVID research saves time, assists clinician care, and improves patient outcomes.

Keep reading

Sign in to your account